Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasrallah

Showing results (71-80 of 1,946) with videos related to

Pageof 195
Sort By:
Schizophrenia Research|March 7, 2018
Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortalityHenry A Nasrallah
The Journal of Clinical Psychiatry|August 19, 2005
Neurologic comorbidities in schizophreniaHenry A Nasrallah
The Journal of Clinical Psychiatry|February 9, 2007
Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyondHenry A Nasrallah
Acta Psychiatrica Scandinavica|March 16, 2007
The case for long-acting antipsychotic agents in the post-CATIE eraH A Nasrallah
The American Journal of Psychiatry|October 5, 2010
Linkage of cognitive impairments with metabolic disorders in schizophreniaHenry A Nasrallah
Psychopharmacology Bulletin|April 1, 1982
Hemispheric asymmetry in affective disordersH A Nasrallah
Primary Care|December 1, 1985
Circumcision: pros and consP F Nasrallah
The Plant Cell|September 22, 2009
A dual role for the S-locus receptor kinase in self-incompatibility and pistil development revealed by an Arabidopsis rdr6 mutationTitima Tantikanjana, Noreen Rizvi, Mikhail E Nasrallah, et al.
Urology|April 1, 1982
Contralateral reflux after unilateral reimplantationP F Nasrallah
Schizophrenia Research|November 20, 2021
Re-inventing the schizophrenia syndrome: The elusive "theory of everything"Henry A Nasrallah
Pageof 195

Showing results (71-80 of 1,946) with videos related to

Sort By:
Pageof 195
Schizophrenia Research|March 7, 2018
Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortalityHenry A Nasrallah
The Journal of Clinical Psychiatry|August 19, 2005
Neurologic comorbidities in schizophreniaHenry A Nasrallah
The Journal of Clinical Psychiatry|February 9, 2007
Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyondHenry A Nasrallah
Acta Psychiatrica Scandinavica|March 16, 2007
The case for long-acting antipsychotic agents in the post-CATIE eraH A Nasrallah
The American Journal of Psychiatry|October 5, 2010
Linkage of cognitive impairments with metabolic disorders in schizophreniaHenry A Nasrallah
Psychopharmacology Bulletin|April 1, 1982
Hemispheric asymmetry in affective disordersH A Nasrallah
Primary Care|December 1, 1985
Circumcision: pros and consP F Nasrallah
The Plant Cell|September 22, 2009
A dual role for the S-locus receptor kinase in self-incompatibility and pistil development revealed by an Arabidopsis rdr6 mutationTitima Tantikanjana, Noreen Rizvi, Mikhail E Nasrallah, et al.
Urology|April 1, 1982
Contralateral reflux after unilateral reimplantationP F Nasrallah
Schizophrenia Research|November 20, 2021
Re-inventing the schizophrenia syndrome: The elusive "theory of everything"Henry A Nasrallah
Pageof 195